191 related articles for article (PubMed ID: 34970238)
1. Pharmacodynamics of Linezolid Plus Fosfomycin Against Vancomycin-Resistant
Wang S; Liu H; Mao J; Peng Y; Yan Y; Li Y; Zhang N; Jiang L; Liu Y; Li J; Huang X
Front Microbiol; 2021; 12():779885. PubMed ID: 34970238
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
Lagatolla C; Milic J; Imperi F; Cervoni M; Bressan R; Luzzati R; Di Bella S
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115241. PubMed ID: 33130503
[TBL] [Abstract][Full Text] [Related]
3. Dose Optimization of Combined Linezolid and Fosfomycin against
Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A
Qi C; Xu S; Wu M; Zhu S; Liu Y; Huang H; Zhang G; Li J; Huang X
Infect Drug Resist; 2019; 12():3497-3505. PubMed ID: 31814738
[TBL] [Abstract][Full Text] [Related]
5. Fosfomycin Enhances the Inhibition Ability of Linezolid Against Biofilms of Vancomycin-Resistant
Chi J; Li Y; Zhang N; Liu H; Chen Z; Li J; Huang X
Infect Drug Resist; 2023; 16():7707-7719. PubMed ID: 38144225
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant
Li Y; Peng Y; Zhang N; Liu H; Mao J; Yan Y; Wang S; Yang G; Liu Y; Li J; Huang X
Infect Drug Resist; 2022; 15():4995-5010. PubMed ID: 36065277
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
[TBL] [Abstract][Full Text] [Related]
8. Virulence and resistance pattern of a novel sequence type of linezolid-resistant Enterococcus faecium identified by whole-genome sequencing.
do Prado GVB; Marchi AP; Moreno LZ; Rizek C; Amigo U; Moreno AM; Rossi F; Guimaraes T; Levin AS; Costa SF
J Glob Antimicrob Resist; 2016 Sep; 6():27-31. PubMed ID: 27530835
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium.
Davis H; Brown R; Ashcraft D; Pankey G
J Glob Antimicrob Resist; 2020 Sep; 22():78-83. PubMed ID: 32007618
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant
Lagatolla C; Mehat JW; La Ragione RM; Luzzati R; Di Bella S
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289992
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant
Mohd Sazlly Lim S; Heffernan A; Naicker S; Wallis S; Roberts JA; Sime FB
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358238
[TBL] [Abstract][Full Text] [Related]
12. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Hall AD; Steed ME; Arias CA; Murray BE; Rybak MJ
Antimicrob Agents Chemother; 2012 Jun; 56(6):3174-80. PubMed ID: 22470111
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo Antibacterial Activity of Linezolid Plus Fosfomycin Against
Xie N; Jiang L; Chen M; Zhang G; Liu Y; Li J; Huang X
Infect Drug Resist; 2021; 14():639-649. PubMed ID: 33658805
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental Galleria mellonella model.
Li L; Chen H; Liu Y; Xu S; Wu M; Liu Z; Qi C; Zhang G; Li J; Huang X
J Microbiol Immunol Infect; 2020 Oct; 53(5):731-738. PubMed ID: 30638785
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Pachón-Ibáñez ME; Ribes S; Domínguez MA; Fernández R; Tubau F; Ariza J; Gudiol F; Cabellos C
Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):89-95. PubMed ID: 20844913
[TBL] [Abstract][Full Text] [Related]
17. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
[TBL] [Abstract][Full Text] [Related]
18. Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.
McLaughlin M; Malczynski M; Qi C; Barajas G; Radetski J; Zembower T; Scheetz MH
Antimicrob Agents Chemother; 2013 Aug; 57(8):3923-7. PubMed ID: 23733458
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
